Search results for: 'modality sensor'

The U.S. Preclinical Small Animal Imaging research service provides comprehensive analyses on the six major modalities used in scientific research laboratories in 2005. The six modalities include: Optical (Bioluminescence and Fluorescence), Micro-PET, Micro-CT, Micro-SPECT, Micro-MRI and High Frequency Ultrasound. Market metrics for all six segment...

01 Jul 2021  |  North America  |  Market Research

Global Computed Tomography Growth Opportunities

Increased Demand and Purchase Parameters on Multivariate Trends Propel Transformational Growth

Infographics

×

An estimated 375 million computed tomography (CT) procedures are carried out globally, increasing annually by 3%–4%. CT has become an indispensable tool in illness diagnosis and management, playing an instrumental role in COVID-19 management. The dynamic CT industry involves many participants introducing technological innovations frequently to ma...

The small animal imaging or in vivo preclinical imaging market began to come into existence from the early 1990s when scientists studying biology and disease processes realized that clinical image could help them reduce the cost of research and time span of their animal studies. At present, medical imaging is an important tool in research applicati...

31 Dec 2019  |  North America  |  Market Research

Global Biometrics Market, Forecast to 2024

eGovernance, Mobile Biometrics and eCommerce Drive the Ubiquity of Biometrics in Commercial and Government Applications

Infographics

×

The global biometrics market is at a high growth stage due to the ubiquity of dominant biometric modalities such as fingerprint and facial recognition. The deployment of biometrics is increasingly pervasive in both governmental and commercial sectors because of ease of use and the high degree of convenience offered by the technology. Key applicatio...

27 May 2021  |  North America  |  Market Research

Improving Customer Journeys with Biometric Authentication Systems

Biometric Technologies Enhance the Customer Experience While Complying with the Highest Security Standards

Infographics

×

The global biometrics market is growing fast because of the ubiquity of some biometric modalities, such as fingerprint and facial recognition. The deployment of biometric technologies is increasing across different business sectors because of their ease of use, high security and assurance, and quick scalability. In recent years, businesses have ...

24 Aug 2021  |  North America  |  Market Research

US and EU Biotech Industry VC Investment Growth Opportunities

Future Growth Potential Driven by Next-generation Cell and Gene Platform Technology Powered by AI

Infographics

×

With this research service, Frost & Sullivan provides critical insights into the biotech, and cell and gene therapy (CGT) venture capital (VC) investment trends highlighting the growth opportunities, key countries in the VC environment, and major trends in cell and gene therapy segment. The study also identifies actionable growth opportunities for ...

06 Mar 2017  |  North America  |  Market Research

Analysis of the United States Molecular Imaging Equipment and Radiopharmaceuticals Market, Forecast to 2023

Technology Advances and New Radiopharmaceuticals Maintain the Industry on a Growth Track

Infographics

×

Molecular imaging can easily be described as the next frontier of medical imaging. In an era of value-based reimbursement, molecular imaging is set to play a significant role in quicker diagnosis, more accurate disease staging, and selection of targeted treatments. Launch of new radiopharmaceuticals across clinical areas other than cardiology and o...

31 May 2022  |  North America  |  Market Research

Global RNA Therapeutics Growth Opportunities

Future Growth Potential Driven by Co-Development Programs and Robust Clinical Trials for Diverse Disease Areas

Infographics

×

Scientific advancements in nucleic acid-based therapies have significantly impacted the global biopharmaceutical industry. The ribonucleic acid (RNA) therapeutics market is expected to witness remarkable clinical progress as therapies target “undruggable” pathways. Technologically advanced platforms are integrated into RNA therapeutics bioprocessin...

Liquid biopsy (CTCs and ctDNAs) is slowly gaining momentum in clinical care given its advantages over the traditional tissue-based gold standard methods. Short-term applications in cancer care range from risk assessment to cancer recurrence monitoring. Despite the proven advantages, there is still a significant number of barriers to adoption such a...